申请人:SPV THERAPEUTICS INC.
                            
                            
                                公开号:US20220220103A1
                            
                            
                                公开(公告)日:2022-07-14
                            
                            Described herein are compounds and their pharmaceutically acceptable salts, pharmaceutical compositions thereof, methods of treatment, and medical uses. The compounds described herein are modulators of cyclin-dependent kinases, and are useful in the treatment or alleviation of protein kinase associated disorders, including cancer, infectious diseases, autoimmune diseases, or cardiovascular diseases.